The American Red Cross Cell and Gene Therapy Solutions is a nationwide leader in providing customized products and services to support your cell and gene therapy needs. Our services include autologous CAR-T collection for clinical trials in addition to all current FDA-approved T-cell therapies. We provide processing and storage within our five cellular therapy labs. In addition, we offer RUO and GMP allogeneic starting materials that can be used to support your needs from bench research through commercialization. With a national network of apheresis collection sites, we have access to a large pool of recallable donors, allowing us to scale up to meet growing needs. Our Quality Management System provides one set of standards that limits variability, ensuring consistency of our products. With this expansive end-to-end process of both autologous and allogeneic services, our customized approach enables maximum speed and confidence as more therapies bring advanced patient care.